✦ LIBER ✦

Re: Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients with Renal Cell Carcinoma

✍ Scribed by Taneja, Samir S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Placebo-Controlled Randomized D

✍ Ornstein, D.K.; Finley, D.S. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 56 KB

Re: A Phase 2 Trial of Sunitinib in Pati

✍ Taneja, Samir S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 103 KB

A Phase II Study of GW786034 Using a Ran

✍ Thomas E. Hutson; Ronald M. Bukowski 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 857 KB

Randomized Phase II Trial of First-Line

✍ Coplen, D.E. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 69 KB

A phase II trial of continuous low-dose

✍ Monika K. Krzyzanowska; Ian F. Tannock; Gina Lockwood; Jennifer Knox; Malcolm Mo 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB

A phase II study of the efficacy and saf

✍ Patrick Schöffski; Jorge A. Garcia; Walter M. Stadler; Thierry Gil; Eric Jonasch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB